Asian Spectator

Men's Weekly

.

TÜV SÜD Appoints Interim Leadership Following CEO Transition

MUNICH, GERMANY – NEWSAKTUELL - 10 July 2025 - The Supervisory Board of TÜV SÜD AG has appointed Ishan Palit, former Asia Pacific CEO, as Interim Chief Executive Officer (Chairman of ...

YAYING Launches 2020 Couture Collection

BEIJING, Nov. 6, 2019 /PRNewswire-Asianet/ -- YAYING launches its 2020 haute couture collection in its debut solo fashion show. Set against the backdrop of central Beijing, on the rooftop of...

CMEE 2020 Promotes Development and Cooperation in Marine Economy

SHENZHEN, CHINA, Sep 27, 2020 - (ACN Newswire) - The China Marine Economy Expo (CMEE) 2020 will be held October 15-18, 2020 at the Convention & Exhibition Center in Shenzhen, China. A c...

Blue paper on evaluation of China's cruise ports in 2018 released

BEIJING, China, Jan. 11, 2019 /Xinhua-AsiaNet/-- The first blue paper on evaluation of China's cruise ports in 2018 was released in Beijing on Wednesday, aiming to guide China's domestic cru...

Etiqa Insurance Singapore’s With You for the Ride Campaign Embeds Itself in Singaporeans’ Daily Lives

SINGAPORE - Media OutReach - 16 October 2023 - Etiqa Insurance Singapore, a leading insurance provider, has unveiled the first 3D captivating interactive installation at the Dhoby Ghaut M...

Etiqa Insurance Singapore returns as the Official NATAS Sponsor and Travel Partner for 2024

SINGAPORE - Media OutReach Newswire - 21 February 2024 - Etiqa Insurance Singapore, a leading general and life insurer, today announced its continued sponsorship of the 2024 National Associ...

Infosys (NYSE: INFY) Announces Results for the Quarter Ended D...

BENGALURU, India, Jan. 11, 2019 /PRNewswire-AsiaNet/-- 10.1% CC YoY Revenue Growth in Q3 Leads to Upward Revision in Guidance"With increased client relevance, we saw double digit (10.1%) yea...

Huawei and More Than 30 Industry Partners Establish an Industr...

SHANGHAI, July 2, 2019 /PRNewswire-AsiaNet/ -- -"Differentiated & Deterministic" 5G Capabilities to Enable Thousands of IndustriesAt MWC 19 Shanghai, 5G Deterministic Networking Summit w...

Shaping the future: How Zhejiang University transforms lives

HANGZHOU, China, Jan.14, 2019/Xinhua-AsiaNet/-- Responsibility. Hard work. Loyalty. These are the three tenets of a good life according to Zhejiang University Associate Professor Imran Haide...

Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis

Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis

Adelaide, AUS, Apr 9, 2020 - (ACN Newswire) - Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance Clinical clients during this difficult time.

Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis

Avance Clinical is a medium-sized full-service CRO known for its nimble and collaborative approach, with more than 20-years of experience in managing early phase trials.

Avance Clinical's Chief Strategist Ben Edwards said a key factor in sponsor demand is the speed and attractive cost of running trials in Australia. In particular, they include:

- The Australian Government financial rebate of more than 40% on clinical trial spend- No IND required for clinical trials and streamlined regulatory processes- Advanced medical, research and scientific community, leading investigators and KOLs, and modern medical facilities

Watch video - how we work here https://www.avancecro.com/

Avance Clinical CEO Yvonne Lungershausen, who has a background in pure research, said sponsors saw the value of running studies in Australia.

"In addition, Australia is not as hard hit by the COVID-19 crisis which has meant we can work with sites to deliver studies that might otherwise be put on hold, costing time and money and causing crippling delays to drug pipelines," said Ms Lungershausen."We are pleased to be the Australian CRO of choice for international sponsors," she said.

"Australia's reputation for FDA compliant scientific and research excellence, its advanced healthcare, and the opportunity to access patients in a less clinical trial competitive environment further reinforces its advantage as a destination for clinical trials."

For more information about the benefits of running your next study in Australia contact us: https://www.avancecro.com/contact-us/

About Avance Clinical

Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organisations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.

Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.

Avance Clinical offers high quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialised patient groups. Other benefits include:

1. The Government R&D grant means more than 40% rebate on clinical trial spend2. Telehealth pivot during COVID-19 pandemic - speed and continuity3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks4. No IND required for clinical trials5. Full GMP material is not mandated for Phase I clinical trials6. Established clinical trial environment with world-class Investigators and sites7. Established healthy subject databases and specialised patient populations8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care9. Major hospitals with world class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasons.

Media Contact: media@avancecro.comChris Thompson

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Diplomasi emosional: Bagaimana rasa marah dan takut dapat membentuk arah kebijakan global

Gambar Perdana Menteri Israel Benjamin Netanyahu (kiri) dan Pemimpin Tertinggi Iran Ayatollah Ali Khamenei di layar, merefleksikan perang antara Iran dan Israel.Mmiss.cabul/Shutterstock● Memanas...

Riset: Populasi hewan langka anoa dan babirusa di pulau kecil lebih tangguh, meski jumlahnya sedikit

● Populasi satwa di pulau kecil terbukti lebih tangguh secara genetik meski jumlahnya sedikit.● Pulau kecil dapat menjadi habitat alami yang penting bagi kelangsungan hewan langka.● ...

6 bulan Makan Bergizi Gratis: Program kesehatan atau bantuan sosial?

Program Makan Bergizi Gratis (MBG) jadi program mercusuar pemerintahan Prabowo-Gibran yang sudah berlangsung selama lebih dari enam bulan. Inisiatif ini menyasar kelompok-kelompok yang rentan mengalam...